Mangalam Drugs & Organics informs about unaudited financial results

20 Nov 2017 Evaluate

Mangalam Drugs & Organics has informed about Unaudited Financial Results for the quarter and half year ended 30th September, 2017 along with Limited Review Report and the Statement of Assets & Liabilities of the said period in the prescribed form which have been taken on record and approved by the Board of Directors.

The above information is a part of company’s filings submitted to BSE.

Mangalam Drugs&Org. Share Price

23.25 -0.59 (-2.47%)
29-Dec-2025 13:22 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1723.10
Dr. Reddys Lab 1265.75
Cipla 1497.70
Zydus Lifesciences 904.50
Lupin 2091.70
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×